China NMPA Newsletter – January 2023


2023-02-28

Featured Articles

NMPA New Approvals in January 2023

In January 2023, NMPA approved 124 medical devices, including 11 Class III imported products, 12 Class II imported products, and 99 Class III domestic products.

Below is a list of approved Class III and Class II imported products in January 2023.

Medical Device/IVDManufacturerCategory
Cardiac Resynchronization Device Tiered-therapy Cardioverter/DefibrillatorSt. Jude Medical Coordination Center BVBAClass III
Bio-Medicus Life Support Catheter and IntroducerMedtronic, Inc.Class III
BD Vacutainer® Safety-Lok™ Blood Collection SetBecton Dickinson and CompanyClass III
Belotero Volume LidocaineAnteis SAClass III
Athletis OVER-THE-WIRE PTA Balloon Dilatation CatheterBoston Scientific CorporationClass III
Restylane VolymeQ-Med ABClass III
TiBases and ScrewsZfx GmbHClass III
Medical X-Ray angiography equipmentGE MEDICAL SYSTEMS SCSClass III
Diagnostic Ultrasound SystemESAOTE S.p.A.Class III
Ultrasound Diagnostic EquipmentSUPERSONIC IMAGINEClass III
Cardiac Resynchronization Device Tiered-therapy Cardioverter/DefibrillatorSt.Jude Medical Coordination Center BVBAClass III
Dissecting ToolsMedtronic Powered Surgical SolutionsClass II
Riptide™ Large Bore Aspiration TubingMicro Therapeutics, Inc.DBA ev3 NeurovascularClass II
Vertebroplasty AdjunctsSeawon Meditech Co., Ltd.Class II
Subcyclo ProbeQUANTEL MEDICALClass II
HDL Cholesterol Calibrator (HDLC CAL)Class II
QUANTA-Lyser 3000 ELISA/IFA + IncubatorINOVA Diagnostics, Inc.Class II
Automatic air mattress systemsCare of Sweden ABClass II
Mobile ECG Atrial Fibrillation Alert Software삼성전자(주)Class II
Wrist0x2 Pulse 0ximeterNonin Medical,Inc.Class II
Diagnostic X-Ray tubeVAREX IMAGING CORPORATIONClass II
Skater FixArgon Medical Devices, Inc.Class II
Aqua Maris® Strong nasal sprayJadran-Galenski laboratorij d.d.Class II

READ MORE…

NMPA CMDE Annual Report for Year 2022

The Center For Medical Device Evaluation of NMPA (NMPA CMDE for short) has made a summary of the work in 2022, the report is as follows:

Ⅰ. Registration application

It accepted 20,865 applications for registration of medical devices, including 5,389 filing changes, 2,035 imported Class I filing. A total of 13,066 applications were transferred to the technical review process, the transfer of the finalized project 14,486, 1,300 more than in 2021, an increase of 9.9 percent year-on-year.

II. Emergency Review Status

III. Review time

Application Type Product Category Average review time Average time for expert consultation Average time for applicant supplementary phase Total time
Product Registration Class II 72 0 245 317
Class III 99 1 178 278
Class II+Class III 95 1 187 283
Registration change of permitted matters Class II 45 0 81 126
Class III 69 0 60 129
Class II+Class III 64 0 64 128
Renewal Registration Class II 24 0 13 37
Class III 46 0 28 74
Class II+Class III 39 0 24 62

IV. Collective decision-making

Ⅴ. Deficiency letter, expert panel meeting and audit

  1. Supplementary Information for deficiency letter
    Issued 5,698 deficiency letters
    Received 5,626 items of supplementary dossiers
  2. Expert panel meeting
    Initiated 114 expert panel meetings
    Organized 107 expert panel meetings
  3. QMS audit
    Initiated 2,465 QMS audits
    Received 2,125 auditing results

Ⅵ. Innovation and priority review

Special review of innovative medical devices

  1. Received 343 innovation applications, up 37.8% year-on-year;
  2. Organized and held 309 expert review meetings;
  3. Completed review of 361 items.

Priority approval for medical device audits

  1. Received 31 priority approval requests, down 24.4% year-on-year;
  2. Organized 13 expert review meetings;
  3. Completed the review of 34 items.

Ⅶ. Manufacturer consulting

Provided 7,717 times ofpre-acceptance consultation
Provided 6,466 times of supplementary dossier consultation

READ MORE…

The Ministry Of Finance of China Reduces Tariffs On Imported Medical Devices

To protect human health and reduce patients’ economic burden, the Ministry of Finance of the People’s Republic of China issued the tariff adjustment plan on December 29, and will reduce import tariffs for 13 types of medical devices from January 1, 2023; and 37 types of medical device products will achieve zero import tariffs.

Policy Highlights

Further reduction of import tariffs for some medical devices

China will implement provisional import tax rates lower than the most-favored-nation (MFN) tariff rate for 1020 items. Among them, 13 types of medical devices such as spring rings, dentures, raw materials for vascular stents and contrast agents will achieve further reduction in import tariffs starting Jan 1, 2023.

Zero import tariff for some medical devices

The eighth step of tariff reduction will be implemented for the MFN tariff rate of the products listed in the Amendment to the Tariff Concession Schedule of the World Trade Organization Accession Protocol of the People’s Republic of China for the expansion of the information technology agreement. After the implementation of the policy, 37 types of medical device products will achieve zero tariff on imports starting July 1, 2023.

New tax item for surgical robots

In the adjustment of import and export tariffs, it is clear that surgical robot tax items will be increased in 2023 to meet the needs of industrial development and scientific and technological progress. Surgical robot refers to a medical device consisting of a robotic arm, console, imaging system and other components that can perform complex surgical operations in a minimally invasive manner. Including orthopedic surgery robot, neurosurgery robot, radiation interventional surgery robots.

READ MORE…

NMPA Facilitates the Usage of Medical Device Master Files

The NMPA issued a notice on further clarifying matters related to the registration and use of the master files of medical devices on January 18, 2023.

Combined with the registration and use of medical device master files, the following matters are clarified:

  1. Medical device master file is a form of technical data, such data is submitted directly by its owner to the medical device regulator, used to authorize the applicant for registration of medical device products in the declaration of medical device registration and other matters. The registration of medical device master file is a voluntary act.
  2. Medical device master file registration is mainly related to medical device raw materials. Medical device master file system applies to the medical device registration applicant in China’s imports of Class II, Class III and domestic Class III medical devices (including in vitro diagnostic reagents) registration, changes, clinical trial approval and other applications referenced in the registration of the master file. According to the actual situation, local NMPA can carry out the main file registration items of domestic Class II medical devices by referring to this announcement.

READ MORE…

New China CER Website

The new website was built based on the newly updated clinical evaluation requirements and regulation in China under the Order 739.

We are here to help you obtain China market approval for your medical devices with a comprehensive Clinical Evaluation Report (CER). Before jumping to any conclusions, use our newly developed tool for a

Resources – Webinar/Short Videos

Please click here to review the record of BradyKnows webinar and short videos.

Resources – FAQ